1242822-57-6 Usage
General Description
(2-Bromo-6-chlorophenyl)methanol is a chemical compound that belongs to the class of benzyl alcohols. It is known for its antibacterial and antifungal properties, making it a useful ingredient in pharmaceuticals and personal care products. It is commonly used as a preservative in cosmetics and toiletries to extend the shelf life of the products and prevent bacterial or fungal growth. This chemical has also been studied for potential use in agricultural applications as a pesticide or fungicide. Additionally, it has been investigated for its potential use in the synthesis of various pharmaceutical compounds. However, it is important to handle and use this chemical with caution as it may be harmful if ingested, inhaled, or comes into contact with skin or eyes.
Check Digit Verification of cas no
The CAS Registry Mumber 1242822-57-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,2,8,2 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1242822-57:
(9*1)+(8*2)+(7*4)+(6*2)+(5*8)+(4*2)+(3*2)+(2*5)+(1*7)=136
136 % 10 = 6
So 1242822-57-6 is a valid CAS Registry Number.
1242822-57-6Relevant articles and documents
ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC MODULATORS
-
Page/Page column 57, (2021/02/19)
The present invention provides new arylsulfonamide compounds having the general formula (I), wherein L, R1, R2, R3 and R4are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as mGLUR4 negative allosteric modulators.
SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
-
Paragraph 0171; 0172; 0186; 0187, (2018/11/21)
The present invention relates to compounds according to Formula I: and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
SUBSTITUTED INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF
-
Paragraph 00149, (2017/05/17)
The present invention relates to compounds according to Formula (I) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
